foundationone.com
FoundationOne
http://www.foundationone.com/index.php
Interactive Cancer Explorer™. How is the Genomic Profiling Approach Different? FAQs: Physicians and Healthcare Providers. WITH TUMOR MUTATIONAL BURDEN. Today there’s more opportunity for doctors to. Counsel better, forecast better, plan better. Accuracy. It's in our DNA. Introducing FoundationACT, our best-in-class,. Reliable blood-based circulating tumor DNA assay. Analytic validation and clinical. That more than 30% NSCLC patients with ALK fusions may have tested negatively for ALK by FISH*? If you are...
investors.foundationmedicine.com
Quarterly Results - Foundation Medicine
http://investors.foundationmedicine.com/results.cfm
Interactive Cancer Explorer™. Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights. Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights. Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook. Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights. Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights.
investors.foundationmedicine.com
Investor FAQs - Foundation Medicine
http://investors.foundationmedicine.com/faq.cfm
Interactive Cancer Explorer™. Where is Foundation Medicine's corporate headquarters located? Foundation Medicine is headquartered at 150 Second Street, Cambridge, MA 02141. The main phone number is (617) 418-2200. Where is the company incorporated? Foundation Medicine is incorporated in the state of Delaware. Where is Foundation Medicine's stock traded? Foundation Medicine is traded on the NASDAQ global stock exchange under the ticker symbol FMI, and its CUSIP number is 350465 100. If delivering by mail:.
investors.foundationmedicine.com
SEC Filings - Foundation Medicine
http://investors.foundationmedicine.com/sec.cfm
Interactive Cancer Explorer™. All Filings (excluding Section 16). Aug 23, 2016. Hesslein, robert w. Aug 11, 2016. Kafka, steven j. Aug 9, 2016. Aug 3, 2016. Aug 2, 2016. Jul 6, 2016. Pellini, michael j. Jul 6, 2016. Miller, vincent a. Jul 6, 2016. Kafka, steven j. Jul 6, 2016. Hesslein, robert w. Jul 6, 2016. 2016 Foundation Medicine, Inc. Foundation Medicine and FoundationOne are registered trademarks and Interactive Cancer Explorer™ is a trademark of Foundation Medicine, Inc.
foundationmedicine.com
Leadership – Foundation Medicine
http://www.foundationmedicine.com/leadership-2
Investors & Press. Events & Presentations. Patients & Caregivers. Foundation Medicine is an example of the right people coming together at the right place and the right time with an important vision. Our management team has a breadth of experience in medical practice, life sciences, genomics, pharmaceuticals, biotechnology, and the clinical diagnostics and laboratory industries as well as a world-class track record in building successful organizations in the field. Michael Pellini, MD. Steven Kafka, PhD.
foundationmedicine.com
News – Foundation Medicine
http://www.foundationmedicine.com/category/news
Investors & Press. Events & Presentations. Patients & Caregivers. At Foundation Medicine, we are strong believers in the power of a community to make change. The sharing of ideas, opinions, stories, and discoveries can lead to new insights and important connections that wouldn’t otherwise be made. The transformation in cancer care is no different. Through Foundation Forward. August 22, 2016. Vincent Miller, MD, Chief Medical Officer, Foundation Medicine. June 29, 2016. Every day at Foundation Medicine, o...
foundationmedicine.com
Teams – Foundation Medicine
http://www.foundationmedicine.com/teams-2
Investors & Press. Events & Presentations. Patients & Caregivers. Our company is grounded in the proven science and medicine that underpins everything we do. It is the passion and drive of every member of our Medical and Scientific team to advance our science and services in collaboration with the broader oncology community to both transform cancer care and move the entire field of oncology forward. Our Technology team works closely with the rest of the organization and our partners to discover new ways ...